Celcuity Inc. (NASDAQ:CELC) headquartered in Minneapolis, will host a conference call for the investment community to discuss the 3Q20 financial results on 9th November 2020 at 4:30 PM Eastern Time.
The conference call will also be webcast live under the investor relations section of the website www.celcuity.com
Earnings Expectation
Celcuity Inc. is expected to report third quarter earnings results, after market close, on Monday 9th November 2020. Analysts polled by Thomson Reuters anticipate third quarter loss of $ 0.23 per share. Looking ahead, the full year loss are expected at $ 0.82 per share.
Celcuity Inc., a cellular analysis company, discovers cancer sub-types and commercializes diagnostic tests to enhance the clinical outcomes of cancer patients treated with targeted therapies in the United States. The companys CELx diagnostic platform uses a patients living tumor cells to identify the specific abnormal cellular process driving a patients cancer and the targeted therapy that treats it. It is developing CELx HSF test to diagnose two new sub-types of HER2-negative breast cancer.
